Lv51
980 积分 2022-06-15 加入
[Guidelines on clinical practice of molecular tests in non-small cell lung cancer in China (2024 version)]
3个月前
已完结
PI3K/AKT/mTOR inhibitors for hormone receptor-positive advanced breast cancer
3个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
4个月前
已完结
ALK-positive lung cancer: a moving target
4个月前
已完结
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
8个月前
已完结
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
8个月前
已完结
mRNA-based cancer therapeutics
8个月前
已完结
Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects
8个月前
已完结
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
9个月前
已完结
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
9个月前
已完结
皖公网安备34019202002308
